找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Clinical Pharmacokinetic and Pharmacodynamic Drug Interactions Associated with Antimalarials; Tony K.L. Kiang,Kyle John Wilby,Mary H.H. En

[复制链接]
楼主: 切口
发表于 2025-3-26 21:45:11 | 显示全部楼层
发表于 2025-3-27 04:14:24 | 显示全部楼层
The Roles of SUMO in Metabolic Regulationin 108 countries that are inhabited by approximately 3 billion people. The most recent estimates from the World Health Organization (WHO) (WHO 2014a, b) suggest there were approximately 207 million cases of malaria in 2012 and 627,000 deaths related to the disease. Most deaths occurred among childre
发表于 2025-3-27 07:28:16 | 显示全部楼层
Amanda C. Nottke,Monica P. Colaiácovonergistic combinations and increased therapeutic success. A summary of pharmacological and pharmacokinetic considerations is given in Table 2.1 for chloroquine, amodiaquine, sulfadoxine, pyrimethamine, mefloquine, quinine/quinidine, artemisinin (the artemisinin agents, artemether, artesunate, and di
发表于 2025-3-27 10:28:51 | 显示全部楼层
Sumo Modification of Ion Channelsalarials include the following: chloroquine, amodiaquine, sulfadoxine and pyrimethamine, mefloquine, primaquine, atovaquone, proguanil, quinine, artemisinin, artesunate, artemether, and dihydroartemisin.
发表于 2025-3-27 15:08:48 | 显示全部楼层
发表于 2025-3-27 20:19:16 | 显示全部楼层
发表于 2025-3-28 00:13:07 | 显示全部楼层
Book 2010s.. . .Comprehensive coverage of the new greater and more challenging integration with .NET 3.5 . .Written from a real–world perspective and examines the features offered by LINQ and the Entity Framework that will help solve problems experienced by professional developers . .Contains insight, interp
发表于 2025-3-28 04:20:10 | 显示全部楼层
发表于 2025-3-28 09:00:00 | 显示全部楼层
发表于 2025-3-28 12:29:25 | 显示全部楼层
Der Itô-Kalkül978-3-540-29265-4Series ISSN 2731-3557 Series E-ISSN 2731-3565
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-6-23 19:15
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表